Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Jeong

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Experimental & Molecular Medicine|April 20, 2026
Loss of p300/CBP-associated factor aggravates cardiac remodeling via regulation of CAMKK2 acetylationYongwoon Lim, Anna Jeong, Duk-Hwa Kwon, et al.
The Lancet. Neurology|November 19, 2022
Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trialMichael J Soileau, Jason Aldred, Kumar Budur, et al.
Clinical Parkinsonism & Related Disorders|February 29, 2024
Continuous subcutaneous foslevodopa/foscarbidopa infusion for the treatment of motor fluctuations in Parkinson's disease: Considerations for initiation and maintenanceVictor S C Fung, Jason Aldred, Martha P Arroyo, et al.
Molecular Therapy. Nucleic Acids|December 4, 2023
Circular RNA circSMAD4 regulates cardiac fibrosis by targeting miR-671-5p and <i>FGFR2</i> in cardiac fibroblastsAnna Jeong, Yongwoon Lim, Taewon Kook, et al.
Biological Psychiatry|April 17, 2026
Baseline Mismatch Negativity Amplitude Predicts Direction and Magnitude of Ketamine Effect in Healthy Volunteers - A "Disordinal" EffectMarco Cecchi, Jason Johannesen, Brandon Farley, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Experimental & Molecular Medicine|April 20, 2026
Loss of p300/CBP-associated factor aggravates cardiac remodeling via regulation of CAMKK2 acetylationYongwoon Lim, Anna Jeong, Duk-Hwa Kwon, et al.
The Lancet. Neurology|November 19, 2022
Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trialMichael J Soileau, Jason Aldred, Kumar Budur, et al.
Clinical Parkinsonism & Related Disorders|February 29, 2024
Continuous subcutaneous foslevodopa/foscarbidopa infusion for the treatment of motor fluctuations in Parkinson's disease: Considerations for initiation and maintenanceVictor S C Fung, Jason Aldred, Martha P Arroyo, et al.
Molecular Therapy. Nucleic Acids|December 4, 2023
Circular RNA circSMAD4 regulates cardiac fibrosis by targeting miR-671-5p and <i>FGFR2</i> in cardiac fibroblastsAnna Jeong, Yongwoon Lim, Taewon Kook, et al.
Biological Psychiatry|April 17, 2026
Baseline Mismatch Negativity Amplitude Predicts Direction and Magnitude of Ketamine Effect in Healthy Volunteers - A "Disordinal" EffectMarco Cecchi, Jason Johannesen, Brandon Farley, et al.
Pageof 3